William J. McKenna
- Cardiology and Cardiovascular Medicine top 0.01%
- Molecular Biology top 0.2%
- Surgery top 0.2%
- Epidemiology top 0.2%
- Orthopedics and Sports Medicine top 0.05%
- Co-authors
- Perry ElliottChristine E. SeidmanPetros SyrrisGaetano ThieneSrijita Sen‐ChowdhryHugh WatkinsBarry J. MaronAlida L.P. Caforio
- Topics
- Cardiomyopathy and Myosin Studies (383 papers)Cardiovascular Effects of Exercise (251 papers)Cardiovascular Function and Risk Factors (132 papers)
- Cited by
- Cardiology and Cardiovascular MedicineOrthopedics and Sports MedicineDevelopmental Neuroscience
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
William J. McKenna
698 papers receiving 57.7k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Cardiology and Cardiovascular Medicine 52.8k
- Molecular Biology 12.0k
- Surgery 5.7k
- Epidemiology 5.4k
- Orthopedics and Sports Medicine 4.8k
Countries citing papers authored by William J. McKenna
This map shows the geographic impact of William J. McKenna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. McKenna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. McKenna more than expected).
Fields of papers citing papers by William J. McKenna
This network shows the impact of papers produced by William J. McKenna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. McKenna. The network helps show where William J. McKenna may publish in the future.
Co-authorship network of co-authors of William J. McKenna
This figure shows the co-authorship network connecting the top 25 collaborators of William J. McKenna. A scholar is included among the top collaborators of William J. McKenna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. McKenna. William J. McKenna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathybreakdown → | 2934 |
| 3 | 107 | |
| 4 | 122 | |
| 5 | The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trialbreakdown → | 644 |
| 6 | Heart Rhythm UK Familial Sudden Death Syndromes Statement Development Group. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement. | 1 |
| 7 | Letter regarding article by Norman et al, "Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy" - Response | 0 |
| 8 | Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy - Reply | 0 |
| 9 | Histological and immunohistochemical myocardial abnormalities in early familial dilated cardiomyopathy | 1 |
| 10 | Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Need for an international registry (Reprinted from Circulation Online, March 21, pg E101, 2000) | 1 |
| 11 | A de novo mutation of the troponin T gene in a patient with hypertrophic cardiomyopathy | 1 |
| 12 | Current medical therapy for advanced heart failure (Reprinted from Am Heart, vol 135, pg S231-S248, 1998) | 6 |
| 13 | Computerised QT dispersion measurement and risk stratification in patients with hypertrophic cardiomyopathy | 1 |
| 14 | Prevention of sudden death in young athletes | 1 |
| 15 | Gender differences in survival in patients with advanced heart failure. | 1 |
| 16 | T-wave alternans as a predictor of sudden death in hypertrophic cardiomyopathy | 2 |
| 17 | GENETIC-COUNSELING IN NOONAN SYNDROME | 7 |
| 18 | MANAGEMENT OF ATRIAL-FIBRILLATION IN HYPERTROPHIC CARDIOMYOPATHY | 2 |
| 19 | LACK OF EFFECT OF AMIODARONE ON IMPAIRED LEFT-VENTRICULAR FUNCTION - COMPARISON WITH DISOPYRAMIDE | 1 |
| 20 | INFLUENCE OF AMIODARONE ON SURVIVAL IN HYPERTROPHIC CARDIOMYOPATHY | 5 |
About William J. McKenna
William J. McKenna is a scholar working on Cardiology and Cardiovascular Medicine, Orthopedics and Sports Medicine and Philosophy, having authored 712 papers that have together received 59.9k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (383 papers), Cardiovascular Effects of Exercise (251 papers) and Cardiovascular Function and Risk Factors (132 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (52.8k citations), Orthopedics and Sports Medicine (4.8k citations) and Developmental Neuroscience (902 citations). William J. McKenna has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Perry Elliott, Christine E. Seidman, Petros Syrris, Gaetano Thiene, Srijita Sen‐Chowdhry, Hugh Watkins, Barry J. Maron, Alida L.P. Caforio, John Deanfield and Niall Mahon. Their work appears in journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.